Filing Flows › Comparisons › RVP vs SNOA
Retractable Technologies vs Sonoma Pharmaceuticals: RVP and SNOA compared
Retractable Technologies is the larger company: $7.2M of revenue in its latest quarter (Q2 2026) against $6.4M for Sonoma Pharmaceuticals (Q1 FY27). Sonoma Pharmaceuticals is growing faster (+60% against -31% a year earlier). Sonoma Pharmaceuticals is more profitable, with an operating margin of -0.6% against -71.5%.
Where the money goes: RVP and SNOA
Retractable Technologies (RVP) · Q2 2026
Retractable Technologies, Q2 2026: revenue $7.2M (-31% year over year), operating margin -71.5%, net earnings $2.8M, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Sonoma Pharmaceuticals (SNOA) · Q1 FY27
Sonoma Pharmaceuticals, Q1 FY27: revenue $6.4M (+60% year over year), operating margin -0.6%, net loss $330K, operating cash flow −$649K. The chart follows the revenue to costs, profit and cash.
| Retractable Technologies (RVP) | Sonoma Pharmaceuticals (SNOA) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $7.2M | $6.4M |
| Revenue growth, Y/Y | -31% | +60% |
| Operating margin | -71.5% | -0.6% |
| Net earnings | $2.8M | −$330K |
| Net margin | 39.3% | -5.2% |
| Operating cash flow | −$1.7M | −$649K |
Where the revenue comes from
Retractable Technologies
- Syringes: $6.3M (87%)
- EasyPoint Needles: $646K (9%)
- Blood Collection Products: $296K (4%)
- Other Products: $8K (0%)
Questions
Which is bigger, Retractable Technologies or Sonoma Pharmaceuticals?
Retractable Technologies is the larger company: $7.2M of revenue in its latest quarter (Q2 2026) against $6.4M for Sonoma Pharmaceuticals (Q1 FY27).
Is Retractable Technologies or Sonoma Pharmaceuticals growing faster?
Sonoma Pharmaceuticals is growing faster (+60% against -31% a year earlier).
Which is more profitable, Retractable Technologies or Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals is more profitable, with an operating margin of -0.6% against -71.5%.
More: Retractable Technologies earnings · how Retractable Technologies makes money · Sonoma Pharmaceuticals earnings · how Sonoma Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 6, 2026). Fiscal quarters can end on different dates. Not investment advice.